Zoe Karakikla-Mitsakou
The First Ever Interim Review Meeting
The 18th of September 2023 marked a significant milestone for Lupus Europe as the Lupus Europe Board and National Members from across Europe gathered virtually for the first-ever Interim Review Meeting. It was wonderful to see so many familiar faces on the screen! Everyone was united by a common purpose: working together towards a fulfilling life for all people with lupus in Europe, until we have reached a world without lupus.
National Member Spotlight
We were astonished by the passion and commitment of our National Members. It was a delight to hear about the incredible activities they are undertaking in their own countries and communities. Their dedication and the breadth of their work are truly inspiring.
The Purpose of Interim Review Meetings
The Interim Review Meeting is held annually, approximately six months after the Lupus Europe General Assembly. The Interim Review is one of the ways through which we work to ensure National Member Organisations are kept informed on the progress of Lupus Europe initiatives and that members actively participate in discussions on priorities and projects. It is also a great opportunity for the Lupus Europe community to come together to hear about the needs and the amazing work of its members. One of the focal points of the Interim Review Meeting was updating National Members on the progress of Lupus Europe initiatives in 2023 and discussing priorities for the upcoming year, 2024.
Perhaps the most powerful takeaway from the meeting was the sense of unity and solidarity among National Members. Their passion and dedication are a testament to the strength of the Lupus Europe Community.
We extend our heartfelt gratitude to everyone who participated in the Interim Review Meeting. Your presence and contributions were invaluable. Remember, our communication channels are always open. Whether you have questions, ideas, or simply want to connect, do not hesitate to reach out. Together, we are stronger, and together, we will continue to make a difference for people with lupus in Europe.
